141 related articles for article (PubMed ID: 32802165)
1. Analysis of clinicopathological features and prognostic factors of non-Hodgkin's intravascular large B-cell lymphoma.
Liu Y; Ma Y; Zhou H; Zhou X; Shao J
Oncol Lett; 2020 Oct; 20(4):43. PubMed ID: 32802165
[TBL] [Abstract][Full Text] [Related]
2. The natural history of intravascular lymphomatosis.
Fonkem E; Lok E; Robison D; Gautam S; Wong ET
Cancer Med; 2014 Aug; 3(4):1010-24. PubMed ID: 24931821
[TBL] [Abstract][Full Text] [Related]
3. Intravascular lymphomatosis: a study of 20 cases in Thailand and a review of the literature.
Sukpanichnant S; Visuthisakchai S
Clin Lymphoma Myeloma; 2006 Jan; 6(4):319-28. PubMed ID: 16507210
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis factors analysis of 56 cases of non-Hodgkin's lymphoma originating from the nasopharynx].
Li SD; Ba YP; Zhang PW
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):651-653. PubMed ID: 31327206
[No Abstract] [Full Text] [Related]
6. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
7. [Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma].
Wang HT; Yang B; Cai LL; Ran HH; Zhang WY; Zhu HL; Yang Y; Li SX; Fan H; Chi XH; Yu RL; Zhang F; Li BL; Lin J; Zhai B; Yao SQ; Lu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1464-70. PubMed ID: 24370030
[TBL] [Abstract][Full Text] [Related]
8. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
[TBL] [Abstract][Full Text] [Related]
10. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
11. T-cell intravascular lymphomatosis (angiotropic large cell lymphoma): association with Epstein-Barr viral infection.
Au WY; Shek WH; Nicholls J; Tse KM; Todd D; Kwong YL
Histopathology; 1997 Dec; 31(6):563-7. PubMed ID: 9447389
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical prognostic factors of primary refractory Hodgkin's lymphoma].
Filatova LV; Gershanovich ML; Plotnikova AA; Turkevich EA; Ivantsov AO; Klimashevskiĭ VF
Vopr Onkol; 2014; 60(5):625-9. PubMed ID: 25816669
[TBL] [Abstract][Full Text] [Related]
13. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
16. Intravascular large B-cell lymphoma or intravascular lymphomatosis: report of a case diagnosed by testicle biopsy.
Van Droogenbroeck J; Altintas S; Pollefliet C; Schroyens W; Berneman Z
Ann Hematol; 2001 May; 80(5):316-8. PubMed ID: 11446739
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcomes of non-Hodgkin's lymphoma patients with leptomeningeal metastases.
Meng X; Yu J; Fan Q; Li L; Li W; Song Z; Liu X; Jiang Y; Gao M; Zhang H
Int J Clin Oncol; 2018 Aug; 23(4):783-789. PubMed ID: 29558001
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4.
Valsami S; Pappa V; Rontogianni D; Kontsioti F; Papageorgiou E; Dervenoulas J; Karmiris T; Papageorgiou S; Harhalakis N; Xiros N; Nikiforakis E; Economopoulos T
Haematologica; 2007 Oct; 92(10):1343-50. PubMed ID: 17768115
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathological study of 13 cases of intravascular lymphoma: experience in a single institution over a 9-yr period.
Matsue K; Asada N; Takeuchi M; Yamakura M; Kimura S; Odawara J; Aoki T
Eur J Haematol; 2008 Mar; 80(3):236-44. PubMed ID: 18081700
[TBL] [Abstract][Full Text] [Related]
20. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
